Curriculum Vitae

Postdoctoral Scientist: Dr. Norman Y. Liaw


Contact details

    Dr. Norman Y. Liaw
    Institute of Pharmacology and Toxicology,
    University Medical Center Goettingen,
    Robert-Koch-Str. 40, 37075 Goettingen
    Germany

    Tel: +49 (0) 551 39-5775
    Fax: +49 (0) 551 39-5699
    E-mail: norman.liaw[at]med.uni-goettingen.de

Education

2013 PhD
Department of Paediatrics, University of Melbourne, Australia
Heart Research, Murdoch Childrens Research Institute, Melbourne, Australia
2007 BSc (Hons.)
Department of Cardiothoracic Surgery, Monash University, Melbourne, Australia

Academic Career

2014 - Postdoctoral Scientist
Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Germany
2013 - Honorary Research Fellow
Heart Research, Murdoch Childrens Research Institute (Melbourne, Australia)
2013 - Honorary Fellow
Department of Paediatrics, University of Melbourne (Australia)

Fellowships, Awards and Honours

2014 ADUMED Stiftung Projectförderung/Project Grant
2013 Melbourne Abroad Travelling Scholarship and Top-Up (University of Melbourne)
2013 Travel Fellowship (ISHR, World Council)
2012 Best Student Poster Presentation (ISHR, Australasian Section)
2012 Travel Fellowship (ISHR, Australasian Section)

Society Memberships

International Society for Stem Cell Research (ISSCR; since 2018)
Deutsches Gesellschaft für Pharmakologie und Toxikologie (DGPT; since 2018)
Member of the Deutsche Gesellschaft für Kardiologie (DGK; since 2015)
Member of the European Society of Cardiology (ESC; since 2014)
Member of the Deutsches Herz-Kreislaufzentrum (DZHK; since 2014)
Member of the International Society for Heart Research (ISHR, since 2009)

Selected Publications

Sheeran FL, Angerosa J, Liaw NY, Cheung MM, Pepe S. (2019) Adaptations in protein expression and regulated activity of pyruvate dehydrogenase multienzyme complex in human systolic heart failure. Oxid Med Cell Longev. 4532592, doi:10.1155/2019/4532592. [PubMed]
Long C, Li H, Tiburcy M, Rodriguez-Caycedo C, Kyrychenko V, Zhou H, Zhang Y, Min YL, Shelton JM, Mammen PPA, Liaw NY, Zimmermann WH, Bassel-Duby R, Schneider JW, Olson EN. (2018) Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Sci Adv. Jan 31;4(1):eaap9004. doi: 10.1126/sciadv.aap9004. eCollection 2018 Jan. [PubMed]
Borchert T, Huebscher D, Guessoum CI, Tuan-Lam D, Ghadri JR, Schellinger I, Tiburcy M, Liaw NY, Li Y, Haas J, Sossalla S, Huber M, Cyganek L, Jacobshagen C, Dressel R, Raaz U, Nikolae VO, Guan K, Thiele H, Melder B, Wollnik B, Zimmermann WH, Luescher T, Hasenfuss G, Templin G, Streckfuss-Boemeke K. (2017) A patient-specific induced pluripotent stem cell model for Takotsubo (stress) syndrome uncovers catecholamine-dependent altered ß-adrenergic signaling. J Am Coll Cardiol. August 22, 70(8) 975-991. [PubMed]
Liaw NY, Zimmermann WH. (2016) Mechanical stimulation in the engineering of heart muscle. Adv Drug Deliv Rev. 2016 Jan 15;96:156-60. [PubMed]
Pepe S, Liaw NY, Sheeran FL, Hepponstall M, Yong, MS., d’Udekem, Y., Cheung, MMH., Konstantinov, IE. (2013) Effect of remote ischemic preconditioning on phosphorylated protein signalling in children undergoing tetralogy of Fallot repair: a randomised controlled trial. J Am Heart Assoc. 2(3):e000095. [PubMed]
Liaw NY, See Hoe L, Sheeran FL, Cheung MMH, Peart JN, Headrick JP, Pepe S. (2013) Postnatal shifts in ischemic tolerance and cell survival signaling in murine myocardium. Am J Physiol Regul Integr Comp Physiol. 305(10):R1171-81.[PubMed]